PTCommunity News November 2016

Experimental Device Heals Wounds With Low-Frequency Ultrasound
Herceptin Biosimilar Succeeds in Key Breast Cancer Trial
Tardive Dyskinesia Drug Valbenazine Set for FDA Review
U.S. Blood-Collection System Faces Multiple Threats, Study Finds
Will Tighter Prescribing Rules Hurt Patients in Pain?
Skin Cancer Immunotherapy Avelumab Wins Priority Review
FDA Expands Labeling for Leukemia Drug Iclusig
Texas Reports First Local Case of Zika Virus Infection
Deadly Infections Linked to Heart Surgery Device
Trump Picks Obamacare Critic to Lead Health Care Overhaul
Scientists Develop Infection-Detecting Bandages
Potent Antibody Neutralizes Zika Infection in Early Research
FDA on Hot Seat for Clinical Trial Deaths
Gallup Survey: Most Americans Want Changes to Affordable Care Act
21st Century Cures Act Sparks Lobbying Frenzy
Benzodiazepines and Related Drugs Increase Hip Fracture Risk in Alzheimer’s Patients
Researchers Find Potential Therapy for Brain Swelling During Concussion
Hypertension and Prehypertension Underdiagnosed, Undertreated in U.S. Children
Patient Death Halts CAR T-Cell Immunotherapy Trial in Leukemia Again
Lilly’s Solanezumab Fails in Phase 3 Alzheimer’s Trial
Combo Diabetes Treatment Soliqua Wins FDA Nod
FDA Approves Darzalex With Two Standard-of-Care Regimens for Treatment of Multiple Myeloma
Study: Babies Exposed to Zika Virus Developed Microcephaly After Birth
Study Examines Rates, Causes of ED Visits for Adverse Drug Events
Report Identifies Teaching Hospitals That Threaten Patient Safety
More Than 20 Million U.S. Children Lack Sufficient Access to Health Care
Study Finds Key Protein That Binds to LDL Cholesterol
Florida Keys Move Ahead With Trial of Self-Limiting, Gene-Modified Mosquitoes
Report: 18.2 Million People Worldwide Are on HIV Antiretroviral Therapy
Application for Triple-Drug, Single-Inhaler COPD Treatment Submitted to FDA
International Research Collaboration Creates Powerful New Tools to Combat Zika
WHO Secures Global Health Funding for Malaria Vaccine
Menopausal Hormone Therapy Improves Bone Health
Viagra Linked With Reduced Heart Attack Risk and Improved Heart Attack Survival
Former Valeant and Philidor Executives Charged in Fraud and Kickback Scheme
Serious, Highly Drug-Resistant Infections Increasing Among U.S. Children
BACE Inhibitor Receives FDA Fast-Track Designation for Early Alzheimer's Disease
FDA Approves Intrarosa for Postmenopausal Women Experiencing Pain During Sex
Erenumab Significantly Reduces Monthly Migraine Days in Phase 3 Trial
Surgeon General Issues Landmark Report on Alcohol, Drugs, and Health
Photoimmunotherapy ‘Bursts’ Tumors, Spares Nearby Cells
First Head-to-Head Study of Cimzia and Humira in Bio-Naïve RA Patients
Entresto Data Show Long-Term Benefits on Heart Failure Readmissions
Avastin Biosimilar Submitted for FDA Review
CDC Announces ‘Get Smart About Antibiotics Week’
Analysts: CMS Hospital Rankings Fail ‘Common Sense Test’
Simple Changes to Antibiotic Treatment May Help Beat MRSA, Researchers Find
Cosentyx Improves Psoriatic Arthritis in Three-Year Study
FDA Approves Defibrillator That Automatically Adjusts Pacing
Heart Risks of Celebrex ‘Dispelled,’ Drugmaker Says
New Medicare List of Most Expensive Drugs Shows Massive Price Hikes
Tiny Super Magnets Could Be Future of Drug Delivery
FDA Says ‘No’ for Now to Hepatitis B Vaccine
RA Treatment Sirukumab Shows Mixed Results Against Humira
Midostaurin Granted Priority Review for AML
USPSTF Recommends Statin Use for Primary Prevention of Cardiovascular Disease in Some Adults
New Combo Therapy Could Cure Hepatitis C in Four Weeks, Researchers Say
FDA Expands Opdivo Indications to Include Head-and-Neck Cancer
Vemlidy Wins FDA Nod as Hepatitis B Medication
Multidrug-Resistant Infection Spreading Globally Among CF Patients
Donald Trump Issues Health Care Mission Statement
HIV Antibody Therapy Ibalizumab Succeeds in Phase 3 Trial
New Screening Test Identifies Potential Therapies to Fight Drug-Resistant Bacteria
Hospital System Creates $10 EpiKit to Compete With EpiPen
Study: Readmission Penalties Are Punishing Safety-Net Hospitals
Report: Obamacare ‘Replacement’ Might Look Familiar
Scientists Develop Hand-Held 'Breathalyzer' to Diagnose Diabetes
‘Zika Can Break Out Anywhere,’ Expert Warns
Disgraced Theranos Hit With $140 Million Lawsuit
Report: CMS Knew About Misclassification of EpiPens Since 2009 But Did Nothing
Trump, GOP Could Use ‘Must-Pass’ Bills to Bring Health Care Changes
Laughing Gas for Labor Pain?
FDA Puts Brakes on Multiple Myeloma Study
Testing of Investigational Zika Vaccine Begins in Humans
Drug Price Hikes Are “Unsustainable,” Medicare Chief Says
Three Health Issues the Candidates Should Have Talked About––But Didn’t
Bayer Submits FDA Application for Stivarga as Liver Cancer Treatment
FDA Advisors Recommend Approval of Solithromycin in Narrow Vote
FDA Approves Expanded Use of Enbrel in Children With Chronic Plaque Psoriasis
Medical Device Tax Becomes Campaign Fodder
Valeant Pharma Sued Over Female Libido Pill
Report: Opdivo/Yervoy Combo May Threaten the Heart
CDC Reports First Cases of Candida auris in United States
Why Did FDA Approve Controversial Muscular Dystrophy Drug Exondys 51?
High Hospital Profits Hurt Medicine, Expert Says
Antitrust Probe Targets Generic Drug Makers
Verubecestat Shows Promise in Alzheimer’s Disease
Blood Clots Dent Hopes for Hemophilia Drug Emicizumab
HHS Adds Five Viruses to Report on Carcinogens
MIT Study: Both Providers and Patients Drive Health Care Spending
FDA’s Drug Approval Team Copes With 700 Unfilled Jobs
Bremelanotide Shows Promise as On-Demand Treatment for Hypoactive Sexual Desire Disorder
Ovarian Cancer Drug Niraparib Submitted to FDA
Study: Common Costly Clot Test Has Few Benefits
FDA Staff Cites Liver Safety Issues With Pneumonia Drug Solithromycin
How to Make Big Bucks Flipping Drugs
Breast Cancer Treatment Ribociclib Wins Priority Review
FDA Accepts Application for Lung Cancer Drug Brigatinib
Pfizer Dumps Cholesterol Drug Bococizumab
Study Links Antibiotic Resistance to Exposure to Chlorhexidine Disinfectants
Survey: Obesity Ties Cancer as Top Health Threat

You are here

PTCommunity News November 2016